Your browser doesn't support javascript.
loading
Misexpression of inactive genes in whole blood is associated with nearby rare structural variants.
Vanderstichele, Thomas; Burnham, Katie L; de Klein, Niek; Tardaguila, Manuel; Howell, Brittany; Walter, Klaudia; Kundu, Kousik; Koeppel, Jonas; Lee, Wanseon; Tokolyi, Alex; Persyn, Elodie; Nath, Artika P; Marten, Jonathan; Petrovski, Slavé; Roberts, David J; Di Angelantonio, Emanuele; Danesh, John; Berton, Alix; Platt, Adam; Butterworth, Adam S; Soranzo, Nicole; Parts, Leopold; Inouye, Michael; Paul, Dirk S; Davenport, Emma E.
Affiliation
  • Vanderstichele T; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
  • Burnham KL; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
  • de Klein N; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
  • Tardaguila M; Human Technopole, Fondazione Human Technopole, Milan, Italy.
  • Howell B; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
  • Walter K; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
  • Kundu K; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK; Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Puddicombe Way, Cambridge, UK.
  • Koeppel J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
  • Lee W; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
  • Tokolyi A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
  • Persyn E; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; Cambridge Baker Systems Genomics Initiative, Department
  • Nath AP; Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • Marten J; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Petrovski S; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Department of Medicine, University of Melbourne, Austin Health, Melbourne, VIC, Australia.
  • Roberts DJ; Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford, UK; Clinical Services, NHS Blood and Transplant, Oxford Centre, John Radcliffe Hospital, Oxford, UK.
  • Di Angelantonio E; Human Technopole, Fondazione Human Technopole, Milan, Italy; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge,
  • Danesh J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambrid
  • Berton A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Molndal, Sweden.
  • Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Butterworth AS; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; British Heart Foundation Centre of Research Excellence,
  • Soranzo N; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK; Human Technopole, Fondazione Human Technopole, Milan, Italy; Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Puddicombe Way, Cambridge, UK; British Heart Foundation Centre of Research Excellence, Univers
  • Parts L; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
  • Inouye M; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; Cambridge Baker Systems Genomics Initiative, Department
  • Paul DS; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; Centre for Genomics Research, Discovery Sciences, BioPha
  • Davenport EE; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. Electronic address: ed5@sanger.ac.uk.
Am J Hum Genet ; 111(8): 1524-1543, 2024 Aug 08.
Article in En | MEDLINE | ID: mdl-39053458
ABSTRACT
Gene misexpression is the aberrant transcription of a gene in a context where it is usually inactive. Despite its known pathological consequences in specific rare diseases, we have a limited understanding of its wider prevalence and mechanisms in humans. To address this, we analyzed gene misexpression in 4,568 whole-blood bulk RNA sequencing samples from INTERVAL study blood donors. We found that while individual misexpression events occur rarely, in aggregate they were found in almost all samples and a third of inactive protein-coding genes. Using 2,821 paired whole-genome and RNA sequencing samples, we identified that misexpression events are enriched in cis for rare structural variants. We established putative mechanisms through which a subset of SVs lead to gene misexpression, including transcriptional readthrough, transcript fusions, and gene inversion. Overall, we develop misexpression as a type of transcriptomic outlier analysis and extend our understanding of the variety of mechanisms by which genetic variants can influence gene expression.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation Limits: Humans Language: En Journal: Am J Hum Genet Year: 2024 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation Limits: Humans Language: En Journal: Am J Hum Genet Year: 2024 Type: Article